Parallax Volatility Advisers
AUPH icon

Parallax Volatility Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Parallax Volatility Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,000
Closed -$24.1K – 1554
2025
Q1 		$24.1K Sell
3,000
-10,200
-77% -$82.6K ﹤0.01% 1413
2024
Q4 		$119K Buy
13,200
+3,000
+29% +$24.5K ﹤0.01% 1728
2024
Q3 		$74.8K Sell
10,200
-9,900
-49% -$61.4K ﹤0.01% 1803
2024
Q2 		$115K Sell
20,100
-83,800
-81% -$441K ﹤0.01% 1685
2024
Q1 		$521K Buy
103,900
+47,000
+83% +$319K ﹤0.01% 1396
2023
Q4 		$512K Buy
56,900
+45,700
+408% +$376K ﹤0.01% 1592
2023
Q3 		$87K Buy
11,200
+10,700
+2,140% +$105K ﹤0.01% 1950
2023
Q2 		$4.84K Sell
500
-32,700
-98% -$339K ﹤0.01% 2221
2023
Q1 		$364K Buy
33,200
+7,500
+29% +$66.1K ﹤0.01% 1829
2022
Q4 		$111K Buy
25,700
+100
+0.4% +$580 ﹤0.01% 2239
2022
Q3 		$192K Buy
+25,600
New +$222K ﹤0.01% 2329
2022
Q2 		– Sell
-400
Closed -$5K – 2870
2022
Q1 		$5K Buy
+400
New +$6.18K ﹤0.01% 2710
2017
Q3 		– Sell
-75,100
Closed -$460K – 2073
2017
Q2 		$460K Sell
75,100
-136,500
-65% -$920K ﹤0.01% 1248
2017
Q1 		$1.55M Sell
211,600
-102,500
-33% -$473K ﹤0.01% 957
2016
Q4 		$660K Buy
+314,100
New +$1.01M ﹤0.01% 1396

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parallax Volatility Advisers's AUPH Position: Q2 2025 in Review

Parallax Volatility Advisers sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 49,279 shares — an estimated $396K sold.

Parallax Volatility Advisers first reported a position in AUPH in Q4 2016 and held it in 17 quarters. The position peaked at $2.51M in Q1 2022. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • Parallax Volatility Advisers reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 49,279 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $396K.
  • Parallax Volatility Advisers first reported a position in Aurinia Pharmaceuticals in Q4 2016 and held it in 17 quarters.
  • Parallax Volatility Advisers's Aurinia Pharmaceuticals position peaked at $2.51M in Q1 2022.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.